Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
ELOVL4 Blocking Peptide (AC1206)
Cat.#: ACPP-1206
Specifications
Despition ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1606 Human GAD2 Protein (AC1606) 50 µg inquiry ACPP-1186 Olig2 Blocking Peptide (AC1186) 250 µg inquiry ACPP-1479 Human TIMP1 Protein, HEK (AC1479) 2 µg inquiry ACPP-1459 Human Midkine Protein, His (AC1459) 5 µg inquiry ACPP-1704 Human CSDC2 Protein (AC1704) 2 µg inquiry ACPP-1318 Orexin A Blocking Peptide (AC1318) 250 µg inquiry ACPP-1743 Human SCG5 Protein (AC1743) 2 µg inquiry ACPP-1447 Human CANX Protein (AC1447) 10 µg inquiry ACPP-1274 Visfatin Blocking Peptide (AC1274) 250 µg inquiry ACPP-1116 Recombinant Human L1CAM Protein (6×His Tag) (AC1116) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket